ARTICLE | Company News
Eleven Biotherapeutics, Roche deal
July 18, 2016 7:00 AM UTC
Eleven will receive a $22.5 million milestone payment from Roche under a June deal granting the pharma exclusive, worldwide rights to develop and commercialize EBI-031. The payment was triggered afte...